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Summary
Objectives Many conservative methods have been applied in the
treatment of pilonidal sinus disease (PSD). The most commonly used
conservative treatment is 80% phenol solution. Our observations
demonstrated that 80% phenol solution caused much destruction in the
sacrococcygeal region.
Design In this study low concentrations of phenol were used with the
aim of reducing the unwanted side-effects of high-concentration phenol
without reducing the therapeutic effects.
Participants We treated 112 patients (18 women, 94 men) with PSD
using phenol solution. Patients were divided into two groups: Group A
was treated with a 40% solution of phenol solution, and Group B was
treated with an 80% solution of phenol solution.
Setting All patients were treated on an outpatient basis. One mL of low
(40%) or high (80%) concentration phenol solution was injected into the
main sinus oriﬁce. During the check it was observed and noted whether
there was skin necrosis, fatty tissue necrosis or abscesses.
Main outcome measures The mean age was 27.4 years (6–44).
The median length of symptoms was seven months (0.5–132). In the 2.8
years (1–6) of mean follow-up period, the disease recurred in 13 (11.6%)
patients.
Results This treatment procedure was well-tolerated by all the patients
except for those who had unwanted results. No patients in group A had
skin necrosis, and only one had abscesses. In group B two patients had
abscesses, and three had skin necrosis. Fatty tissue necrosis was seen in
one patient in Group A and in ﬁve patients in Group B. Recurrence rates
were four (7.4%) cases in Group A and nine (15.5%) cases in Group B.
Conclusions It is possible to treat patients in a shorter time with a
considerably smaller loss of working time, since the destruction of
peripilonidal adipose tissue and skin is less. Therefore, the use of low-
concentration phenol solution is an option to be considered in the
treatment of PSD.
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1Introduction
Sacrococcygeal pilonidal sinus disease (PSD) is a
common problem especially in young hirsute
men. Herbert Mayo is reported to have published
the ﬁrst case of PSD in1833,
1 and many surgical
techniques have been described and performed
since the 1880s as treatment for chronic PSD.
2 Sur-
gical methods generally centre on excision of the
sinus tracts followed by primary midline and off-
midline closure or leaving the wound open to heal
by secondary intention.
3 Some authors have
suggested and applied a sclerosing agent in the
treatment.
4,5 One of the most popular sclerosing
agents is 80% phenol solution,
6 but although it is
applied by many surgeons, it has been demon-
strated that this highly caustic agent causes
much destruction in the sacrococcygeal region
and may extend the period of wound healing
and recovery.
7,8
The objective of this study was to establish the
effectiveness of low (40%) concentrations of
phenol solution in the treatment of sacrococcygeal
pilonidal disease.
Materials and methods
Of the 126 patients admitted with sacrococcygeal
pilonidal disease from October 2004 to November
2009, those who were treated but did not come
back for check-up and those whose purulent
discharge did not stop were eliminated from
the study. All the remaining 112 were admitted
to the protocol and completely followed up.
Ninety-four of our patients were male, and 18
were female. Fifty-four patients received 40%
phenol solution (Group A), and 58 patients
received 80% solution (Group B). Patients were
informed of the risks of the treatment and
informed consents were taken.
All patients were treated on an outpatient basis.
The sacrococcygeal skin was shaved before appli-
cations. The area was cleaned with povidone
iodine solution and covered with gauzes. The
skin, sacrococcygeal fascia and surrounding
tissue of the main sinus and its lateral tracts
were inﬁltrated with approximately 5 mL lido-
caine (concentration 20 mg/mL) with epinephrine
(concentration 0.0125 mg/mL). All sinus tracts
were gently probed. Hair, debris and infected
contents were taken out of the main sinus tract
using a curved mosquito clamp, and then tracts
were curetted bluntly. An intravenous plastic IV
catheter was introduced into the sinus and 1 mL
phenol solution was injected for a total of ﬁve
minutes to Group B patients. In Group A, 0.5 cc
normal saline made up to 1 mL with phenol sol-
ution was injected at the same time and for the
same periods as Group B. The number, length
and position of the sinus canals were not evalu-
ated in our study. Patients who had purulent dis-
charge were given 500 mg Cefuroxime aksetil
(Hoffmann-La Roche Ltd, Basel, Switzerland)
each day for ﬁve days. Patients whose discharge
ceased were included in the study. No antibiotic
was given after the application.
Patients were checked and dressed weekly until
they recovered completely. During the checkstheir
sinus oriﬁces were checked and, if needed, any
necrotic material and blood clots were drained
out by entering the main oriﬁce. After recovery
every patient was advised to clean their interglu-
teal region when bathing and also to depilate the
region every three months. Patients, all of whose
sinus oriﬁces were epitelized and closed, and
those whose discharge had ceased, were accepted
as recovered.
If the purulent discharge did not decrease or if
the oriﬁces did not close, a second application was
performed six weeks later. Repeated discharge
from the sinuses after complete healing was
admitted as recurrence. Skin necrosis, fatty tissue
necrosis, abscesses and recurrence were accepted
as unwanted results. All patients were told to go
to work the following day, but it was suggested
that patients who had the unwanted results
should rest for a short time.
Statistics analysis was evaluated by Kruskal-
Wallis test. In a double comparison, a chi-square
test was used; p < 0.05 was considered signiﬁcant.
Results
The mean age of the whole group was 27.4 years
(range 16–44 years). Five patients in Group A
and seven in Group B had been previously oper-
ated on in other centres. The median duration
of symptoms was eight months (range 0.5–132
months). In the 2.8 years (range 1–4) of mean
follow-up period we did not need to hospitalize
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2any of the patients. This treatment procedure was
well-tolerated by all the patients except for those
who had unwanted results. Table 1 shows a com-
parison of the groups. Patients whose discharge
was continuing only because of abscesses and
fatty tissuewere provided with drainage by widen-
ing their sinus oriﬁce with a mosquito clamp.
Unwanted results were found in 25 (22.3%) of
the patients. Three of these had an abscess, three
had skin necrosis, six had fatty tissue necrosis
and 13 patients had recurrences. Two of the recur-
rent cases of Group A and three from Group B
were operated on as they did not accept a second
phenol solution injection therapy. The other
patients who had recurrence recovered through a
second course of phenol solution. Second appli-
cations were necessary in 13 (11.6%) of the patients
(Table 2). It was decided that the patient had
recovered after a period of at least 1 month
without disease after the sinus oriﬁce had closed.
Group Awas found to be signiﬁcantly different
from Group B in terms of loss of working days, the
duration of recovery and the duration of symp-
toms (p <0.05). Group A was different from B in
terms of unwanted results (p < 0.05).
Discussion
Phenol solution therapy method was ﬁrst
described by Maurice and Greenwood
1 in 1964.
They suggested that it might supply a cure to the
quiescent phase in the treatment of PSD. This
has been studied by many researchers. All of
these studies used phenol at 80% concentration
or the crystallized form.
9,10 This concentration of
phenol solution and the crystallized form was
observed to cause destruction in the pilonidal
cyst cavities, and to narrow lipoid tissue, sacral
fascia and skin. These patients had to stay in the
hospital for several days and lost a considerable
amount of working time. Most researchers advo-
cating the use of phenol have reported a success
rate of between 59% and 95.1% for the treatment,
a repeat rate of 6.3% to 17.1%, and median
healing times of 6.2 to 8.7 weeks. Work days lost
are reported as 8.3–11.6 in the literature.
10–12 In
our study, time taken for wound healing was
shorter in the low concentration phenol group
than in the 80% phenol group. The average
number of working days lost was 3.1 for the 54
patients in the low phenol concentration group,
which was low in terms of the literature, and 8.6
for the 58 patients in the 80% phenol concentration
group, which was comparable with the literature.
Table 2
Comparison of the groups in terms of unwanted
results
A (54
cases)
B (58
cases)
P
value
(40%) (80%)
Abscess 1 2 0.033
Skin necrosis 0 3 0.000
Fatty tissue
necrosis
1 5 0.001
Recurrence 4 9 0.021
Total 6 19 0.014
Table 1
Comparison of the groups
A (40%) B (80%) Total P value
Patients (n) 54 58 112 0.241
Age (years) 28.4 (16–43) 27.1 (18–44) 27.4 (16–44) 0.114
Gender (man/woman) 47/74 7 /11 94/18 0.087
Previous surgery 5 (9.3%) 7 (12.1%) 12 (10.7%) 0.076
Time of follow-up (years) 2.7 (1–4) 2.9 (1–4) 2.8 (1–4) 0.843
Length of symptoms (months) 7 (3–114) 8 (0.5–132) 8 (0.5–132) 0.337
Success rate with one application 48 (88.9%) 39 (67.2%) 87 (77.7%) 0.001
Working time lost (days) 3.1 (0–14) 8.6 (0–42) 4.2 (0–42) 0.003
Time of wound healing (days) 30.5 (11–6) 37.0 (18–88) 29.9 (9–88) 0.046
 Mean and range
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3In our study, as in previous ones, the average
follow-up period was 2.8 years.
As phenol solution treatment can be carried out
on an inpatient basis it compares favourably with
other therapeutic approaches. Shorey
13 reported a
one-day stay in hospital, but in our study no inpa-
tient stay was necessary, and all patients left the
clinic immediately after the procedure.
The most common postoperative complications
after phenol treatment are development of
abscesses and skin and fat tissue necrosis. Compli-
cations such as sterile abscesses and fat and skin
necrosis were seen at a rate of 7–16% in an
earlier study.
14 Many authors ascribed leakage of
phenol into the surrounding tissues as due to
either too much pressure at the time of injection,
or to the opening up of a false tract by preliminary
probing. When we used a low concentration of
phenol solution in patients, there was no skin
necrosis, and only one case of abscess and one of
fatty tissue necrosis.
Results were similar to those of the open tech-
nique.
15 Therefore, some recommend that the
initial management of PSD should be conserva-
tive, since only one in 20 patients is likely to
require surgery. Phenolization seemsto be a prom-
ising technique; however, low concentration
phenol treatment is a technique only possible
with a simple non-infected and uncomplicated
sinus.
16,17 Therefore, if there was purulent dis-
charge, we used 500 mg Cefuroxime aksetil each
day for ﬁve days before application.
Unlike previous studies, we achieved a high
success rate in the low concentration phenol sol-
ution group.
18,19 We think there may be many
reasons for this good result. First, low concen-
tration phenol solution destroyed skin, fat tissue
and the sacral fascia less. Second, we checked
every case every three or four days. Thus, any
unwanted results during the progress of the
healing process were observed. Third, in check-
ups, any necrotic tissue and hematoma which
was blocking the sinus was removed by curettage
and phenol solution in order to prevent infection.
This prevented any infection. Finally, we rec-
ommended shaving of the sacrococcygeal region
every three or four months after recovery. We
believe that this prevented recurrence of PSD.
The results of treatment of phenol solution by
surgical methods are not better than those of
phenol treatment. Mahdy
20 was reported as
performing surgical treatment on 60 patients
divided into two groups, whose hospital stay
was 2.9 days and 4.8 days. In the same study,
loss of working days was reported as 18.3 days
and 25.5 days. Petersen et al.
21 reported a high
relapse rate of about 25% in 60 patients on
whom primary closure surgery was performed.
Mentes ¸ et al.
22 reported that the wound re-opened
in 1.7% and infection occurred in 6.5% of 353
patients on whom surgery was performed. In
our study, 2.8 years of follow-up showed an
average of 4.2 working days lost, acomplete recov-
ery rate of 77.7%, 11.7% with complications, and a
relapse rate of 4.2%.
Position, length and number of sinus canals are
not taken into account, and the average duration
of follow-up of 2.8 years are the reasons for limit-
ing the study. Although the results of low concen-
tration phenol application indicate that there may
be beneﬁts and a low complication rate in the treat-
ment of PSD with low-concentration phenol sol-
ution, prospective randomized studies are needed.
Based on this study, it is difﬁcult to recommend
that this treatment for pilonidal disease should be
applied routinely.
In conclusion, it is possible to treat patients
using low-concentration phenol solution in a
shorter time and with the loss of considerably
fewer working days since there is less destruction
of peripilonidal adipose tissue and skin. For these
reasons, low concentration phenol solution in the
treatment of pilonidal sinus disease is an option
to be considered.
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